Pathstone Family Office’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $204K | Buy |
6,438
+1,086
| +20% | +$34.3K | ﹤0.01% | 1508 |
|
2023
Q2 | $220K | Sell |
5,352
-181
| -3% | -$7.45K | ﹤0.01% | 1100 |
|
2023
Q1 | $206K | Sell |
5,533
-6,095
| -52% | -$227K | ﹤0.01% | 1078 |
|
2022
Q4 | $3.52M | Sell |
11,628
-84
| -0.7% | -$25.4K | 0.03% | 350 |
|
2022
Q3 | $654K | Buy |
11,712
+5,752
| +97% | +$321K | 0.01% | 947 |
|
2022
Q2 | $308K | Buy |
5,960
+2,209
| +59% | +$114K | 0.01% | 781 |
|
2022
Q1 | $273K | Sell |
3,751
-18
| -0.5% | -$1.31K | 0.01% | 784 |
|
2021
Q4 | $445K | Sell |
3,769
-31
| -0.8% | -$3.66K | 0.01% | 597 |
|
2021
Q3 | $509K | Buy |
3,800
+17
| +0.4% | +$2.28K | 0.01% | 505 |
|
2021
Q2 | $613K | Sell |
3,783
-1,322
| -26% | -$214K | 0.02% | 403 |
|
2021
Q1 | $410K | Buy |
5,105
+3,291
| +181% | +$264K | 0.01% | 390 |
|
2020
Q4 | $99K | Hold |
1,814
| – | – | ﹤0.01% | 388 |
|
2020
Q3 | $36K | Hold |
1,814
| – | – | ﹤0.01% | 400 |
|
2020
Q2 | $38K | Hold |
1,814
| – | – | ﹤0.01% | 348 |
|
2020
Q1 | $22K | Hold |
1,814
| – | – | ﹤0.01% | 409 |
|
2019
Q4 | $266K | Hold |
1,814
| – | – | ﹤0.01% | 377 |
|
2019
Q3 | $24K | Hold |
1,814
| – | – | ﹤0.01% | 370 |
|
2019
Q2 | $30K | Hold |
1,814
| – | – | ﹤0.01% | 395 |
|
2019
Q1 | $31K | Hold |
1,814
| – | – | ﹤0.01% | 370 |
|
2018
Q4 | $25K | Hold |
1,814
| – | – | 0.01% | 245 |
|
2018
Q3 | $52K | Buy |
+1,814
| New | +$52K | 0.02% | 100 |
|
2018
Q2 | – | Sell |
-1,814
| Closed | -$38K | – | 270 |
|
2018
Q1 | $38K | Hold |
1,814
| – | – | 0.02% | 119 |
|
2017
Q4 | $35K | Buy |
+1,814
| New | +$35K | 0.02% | 72 |
|
2017
Q3 | – | Sell |
-1,814
| Closed | -$29K | – | 288 |
|
2017
Q2 | $29K | Hold |
1,814
| – | – | 0.01% | 251 |
|
2017
Q1 | $26K | Buy |
+1,814
| New | +$26K | 0.01% | 220 |
|
2016
Q4 | – | Sell |
-1,814
| Closed | -$31K | – | 170 |
|
2016
Q3 | $31K | Hold |
1,814
| – | – | 0.03% | 77 |
|
2016
Q2 | $39K | Buy |
+1,814
| New | +$39K | 0.04% | 62 |
|